Concerning HIV-reverse transcriptase inhibitors, those stimulating eNOS activity, glycolysis and/or fatty acids oxidation (6, 106, 107, 110) (Figure 1, Table 3) could favor tumor-associated vasculogenesis. This evidence concerns the gene NOS3 and neoplasm.